This review will focus on the currently available and potential future treatment methods of MIF in pathological myocardial hypertrophy caused by hypertensive heart disease (HHD), aortic stenosis, diabetic cardiomyopathy, hypertrophic cardiomyopathy and so on. Here, MIF is linked to cardiac hypertrophy.